News
GRTX
0.100
0.00%
0.000
Galera Therapeutics Expands Share Authorization, Enhances Stockholder Rights
TipRanks · 1d ago
Galera Therapeutics bylaws grant shareholders right to act by written consent
PUBT · 1d ago
Galera Therapeutics Q1 EPS $(0.01), Same YoY
Benzinga · 2d ago
Galera net loss widens to $1.61 million in Q1 2026
PUBT · 2d ago
Galera Shareholders Approve Governance Changes and Share Increase
TipRanks · 5d ago
Galera Therapeutics shareholders approve reverse stock split authorization range 1-for-75 to 1-for-200
PUBT · 5d ago
Weekly Report: what happened at GRTX last week (0504-0508)?
Weekly Report · 5d ago
Galera Therapeutics files Form 3 beneficial ownership statement for Emerald Bioventures LLC
PUBT · 05/04 21:58
Weekly Report: what happened at GRTX last week (0427-0501)?
Weekly Report · 05/04 09:35
Weekly Report: what happened at GRTX last week (0420-0424)?
Weekly Report · 04/27 09:36
Weekly Report: what happened at GRTX last week (0413-0417)?
Weekly Report · 04/20 09:35
Galera Therapeutics, Obsidian Therapeutics Announces All-Stock Merger; Stock Up
NASDAQ · 04/15 02:06
Galera, Obsidian secure $350 million private placement financing ahead of merger
PUBT · 04/14 18:18
*Galera Therapeutics, Obsidian Will Apply to Trade on Nasdaq Under Ticker OBX
Dow Jones · 04/14 18:11
*Galera Hldrs Will Retain Contingent Value Right for 95% of All Future Milestones for Up to 10 Years Arising Out of Oct 2025 Asset Purchase Agreement With Biossil.ai
Dow Jones · 04/14 18:10
*Galera Therapeutics, Obsidian to Combine in All-Stock Transaction
Dow Jones · 04/14 18:10
*Galera Therapeutics, Obsidian Combined Co to Operate as Obsidian Therapeutics >GRTX
Dow Jones · 04/14 18:09
*Galera Therapeutics: Private Placement Financing of $350 M Expected to Fund Combined Co Into 2H of 2028 >GRTX
Dow Jones · 04/14 18:09
Press Release: Galera Therapeutics and Obsidian -2-
Dow Jones · 04/14 18:08
Galera Announces Obsidian Merger and $350M Financing
TipRanks · 04/14 14:10
More
Webull provides a variety of real-time GRTX stock news. You can receive the latest news about Galera Therapeutics, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About GRTX
Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing a pan-NOS inhibitor through clinical development for patients with the hardest-to-treat forms of advanced breast cancer.